Q2 2026 Holdings
Filed 2026-08-13 | 35 holdings | $136.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $14.4M | 42,900 | 10.5% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $9.9M | 2,165,997 | 7.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $8.3M | 455,000 | 6.1% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $7.7M | 414,000 | 5.7% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $7.5M | 226,575 | 5.5% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $7.2M | 230,264 | 5.3% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $6.7M | 121,524 | 4.9% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $6.5M | 53,000 | 4.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $5.4M | 133,000 | 4.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $4.5M | 301,000 | 3.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $4.3M | 58,250 | 3.1% |
| Savara Inc(SVRA) | COM | 805111101 | $3.7M | 605,280 | 2.7% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $3.5M | 102,000 | 2.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.0M | 28,497 | 2.2% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $3.0M | 462,355 | 2.2% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $3.0M | 79,700 | 2.2% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $2.9M | 300,000 | 2.2% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $2.9M | 12,000 | 2.2% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $2.7M | 185,000 | 2.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $2.6M | 4,750 | 1.9% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $2.5M | 45,000 | 1.8% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $2.4M | 230,423 | 1.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.3M | 125,000 | 1.7% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $2.3M | 84,168 | 1.7% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $2.2M | 31,813 | 1.6% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $2.2M | 39,000 | 1.6% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $2.2M | 373,128 | 1.6% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $1.9M | 200,000 | 1.4% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $1.9M | 26,900 | 1.4% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $1.7M | 771,000 | 1.2% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.6M | 505,431 | 1.2% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $1.4M | 32,700 | 1.0% |
| Evolus Inc(EOLS) | COM | 30052C107 | $1.0M | 150,000 | 0.8% |
| Celcuity Inc(CELC) | COM | 15102K100 | $418.5K | 4,000 | 0.3% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $325.7K | 500,551 | 0.2% |